Opthea Limited, formerly Circadian Technologies Limited, is engaged in developing and commercializing therapies for cancer and eye diseases. The Company focuses on developing activities that covers targets, including vascular endothelial growth factors (VEGF-C, VEGF-D and VEGF receptor-3). It develops therapies for the treatment of diseases associated with blood and lymphatic vessel growth, such as angiogenesis, lymphangiogenesis and vascular leakage.
Laporan Pasar Australia 6 April memuat: Anak Perusahaan Motopia Limited (ASX:MOT), yaitu cBox Pty Ltd telah ditunjuk sebagai mitra distribusi Australasia dari Business Wire; MACA Limited (ASX:MLD) memberikan layanan pemilihan dan pemecahan biji besi bagi WPG Resources Limited (ASX:WPG); Rey Resources Limited (ASX:REY) mengumumkan kenaikan Sumberdaya Terukur Batubara Termis pada Proyek Duchess Paradise; Circadian Technologies Limited (ASX:CIR) mengatakan bahwa VGX-100 secara signifikan menghambat pertumbuhan dan penyebaran berbagai jenis tumor pada manusia.
© 2024 ABN Newswire. All Rights reserved.